phone monitor calendar cart user pin clock hourglass syringe briefcase redo check download camera med-spa plastic-surgery file Lifted Logic Web Design in Kansas City clock location phone play chevron-down chevron-left chevron-right chevron-up facebook facebook-simple checkbox checkbox-checked radio radio-selected instagram google business profile pinterest twitter youtube send linkedin tiktok circle-calendar circle-camera cart email circle-phone circle-pin circle-clock circle-email user phone circle-monitor left-arrow right-arrow chevron-left-thin chevron-right-thin chevron-down-thin chevron-up-thin chevron-down-medium quotes link chevron-right-medium plus remove filter arrow-box trash circle-user cell fax close

National Tattoo Day

For Immediate Release:


Celebrate the Tattoos you Love and Clear the Ones you Regret with PicoSure® on National Tattoo Day July 17th 2014 at RL Cosmetic Surgery and Medspa

Vernon Hills, IL, July 16, 2014– For those who harbor tattoo regret stemming from outdated art, a messy job, or a symbolic gesture that has lost its significance, National Tattoo Day on Thursday, July 17 will be your chance to start fresh with a clean canvas. Whether the goal is to clean up the lines of an existing tattoo or totally remove it, RL Cosmetic Surgery and Medspa, office of Dr. Daniel Ritacca can help you with the assistance of the first FDA-cleared picosecond aesthetic laser, PicoSure®. Recognized as the first significant improvement in the treatment of tattoo removal in over 20 years, PicoSure can effectively erase tattoos with fewer treatments and better results.

“Just like a relationship, tattoo trends can easily come and go, leaving one wondering years later what the reason, or lack thereof, of getting the tattoo in the first place,” states Dr. Ritacca. “Some people ask to remove all traces of ink, while others choose to cover it up with another tattoo and come in for laser treatments to clean up what can’t be covered.

An unparalleled breakthrough in tattoo removal technology, PicoSure’s PressureWave™ gently delivers ultra-short pulses of energy to the tattoo ink in trillionths of a second without injury to the surrounding skin. This shatters the ink into tiny particles that are easily eliminated by the body. Based on physician studies1,2 PicoSure has proven efficacy on difficult ink colors, as well as previously-treated tattoos, for better clearance with fewer laser treatments and improved recovery time.

According to The America Society for Aesthetic Plastic Surgery (ASAPS), more Americans received tattoo removal treatment in 2013 than in past years. Up by 11% in 2013, tattoo removal has also seen a boost from different age groups as more American adults marked their middle age by trading out their old tattoos. PicoSure has made tattoo removal faster1,2 so if you are looking to clear your existing tattoo in efforts to celebrate a new one call 847-367-8815 to learn how PicoSure can help you clear your canvas.

About RL Cosmetic Surgery and Medspa
At RL Cosmetic Surgery and Medspa, we are dedicated to our patients’ discovery of their ideal self, by helping to achieve a more youthful, attractive appearance and inner well being. We do this through the expertise of team board-certified physicians with over 75 years of combined experience, state of the art aesthetic technology and caring, attentive staff whom are dedicated to treating each patient with honesty, dignity and respect.

For more information, or to arrange a consultation with a patient coordinator about PicoSure, please call 847-367-8815 or visit www.ritaccalasercenter.com or www.chicago-tattooremoval.com.

Sources:
1 Successful and Rapid Treatment of Blue and Green Tattoo Pigment With a Novel Picosecond Laser, Jeremy A. Brauer, MD; Kavitha K. Reddy,
MD; Robert Anolik, MD; Elliot T. Weiss, MD; Julie K. Karen, MD; Elizabeth K. Hale, MD; Lori A. Brightman, MD; Leonard Bernstein, MD;
Roy G. Geronemus, MD, Arch Dermatol. Published online May 21, 2012. doi:10.1001/archdermatol.2012.901

2 Treatment of Tattoos With a Picosecond Alexandrite Laser: A Prospective Trial, Nazanin Saedi, MD; Andrei Metelitsa, MD, FRCPC; Kathleen
Petrell, BS; Kenneth A. Arndt, MD; Jeffrey S. Dover, MD, FRCPC
Arch Dermatol. Published online September 17, 2012. doi:10.1001/archdermatol.2012.2894.

Related News